Papaverine for nerve pain after taxane chemotherapy
Part of Brain & nervous system, Cancer clinical trials.
This study tests whether a drug called papaverine can help relieve nerve pain and numbness caused by taxane-based chemotherapy. You may join if you've already tried standard treatments and still have bothersome symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with cancer (confirmed by biopsy or other tests).
- You have already received a taxane-based chemotherapy (like paclitaxel or docetaxel), and finished it at least 4 weeks ago.
- You still have moderate to severe nerve symptoms (numbness, tingling, or pain) from the chemotherapy.
- You have tried at least one standard treatment for nerve pain (like duloxetine, pregabalin, or gabapentin) for at least 4 weeks without enough relief, or you couldn't tolerate it.
- You are generally in good health otherwise, with acceptable organ function (liver, kidneys, blood counts).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether acupuncture can help reduce nerve pain, numbness, or tingling in hands and feet caused by chemotherapy for gynecologic cancers. You may join if you finished certain chemo at least 3 months ago and still have these symptoms.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
This study looks at “TRP channels,” which are part of how nerves sense pain and temperature, to understand nerve pain (neuropathy) after chemotherapy. It may help improve how future treatments prevent or reduce nerve pain in people who have had certain chemotherapy drugs.
This Phase 2 trial tests duloxetine to see if it safely reduces painful nerve damage caused by chemotherapy (especially taxanes) in people with solid tumors. If you have moderate-to-severe nerve pain and meet lab and heart-safety checks, this study may be an option.
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can reduce nerve pain caused by the chemotherapy drug nab-paclitaxel in breast cancer patients. It may help women who have finished chemo and are still dealing with numbness, tingling, or pain in their hands or feet.
This study tests if virtual group acupuncture can help reduce nerve pain and numbness caused by chemotherapy (called CIPN). It is for people who finished taxane-based chemo for early-stage breast cancer and still have symptoms.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.